OncOlogy

  • Targeting MET in advanced NSCLC care: A multidisciplinary perspective

  • Expert insights on biomarker testing in advanced personalized NSCLC care

  • Biomarker landscape in advanced NSCLC care

  • Insights on KRAS-driven NSCLC

  • Targeting KRAS in Advanced NSCLC

  • Expert perspectives and practical guidance on targeting MET in advanced NSCLC

  • Management of relapsed/ refractory high-risk neuroblastoma

  • Practical considerations for anti-GD2 immunotherapy in neuroblastoma

  • ASH 2020: Therapeutic developments in ALL, NHL, and MM

  • New therapeutic strategies in the management of advanced-stage CTCL